Literature DB >> 21571320

β-blockade protection of bone marrow following trauma: the role of G-CSF.

Gregg M Baranski1, Michael D Offin, Ziad C Sifri, Ihab O Elhassan, Edward J Hannoush, Walter D Alzate, Pranela Rameshwar, David H Livingston, Alicia M Mohr.   

Abstract

BACKGROUND: Following severe trauma, there is a profound elevation of catecholamine that is associated with a persistent anemic state. We have previously shown that β-blockade (βB) prevents erythroid growth suppression and decreases hematopoietic progenitor cell (HPC) mobilization following injury. Under normal conditions, granulocyte colony stimulating factor (G-CSF) triggers the activation of matrix metalloprotease-9 (MMP-9), leading to the egress of progenitor cells from the bone marrow (BM). When sustained, this depletion of BM cellularity may contribute to BM failure. This study seeks to determine if G-CSF plays a role in the βB protection of BM following trauma.
METHODS: Male Sprague-Dawley rats were subjected to either unilateral lung contusion (LC) ± βB, hemorrhagic shock (HS) ± βB, or both LC/HS ± βB. Propranolol (βB) was given immediately following resuscitation. Animals were sacrificed at 3 and 24 h and HPC mobilization was assessed by evaluating BM cellularity and flow cytometric analysis of peripheral blood for HPCs. The concentration of G-CSF and MMP-9 was measured in plasma by ELISA.
RESULTS: BM cellularity is decreased at 3 h following LC, HS, and LC/HS. HS and LC/HS resulted in significant HPC mobilization in the peripheral blood. The addition of βB restored BM cellularity and reduced HPC mobilization. Three h following HS and LC/HS, plasma G-CSF levels more than double, however LC alone showed no change in G-CSF. βB significantly decreased G-CSF in both HS and LC/HS. Similarly, MMP-9 is elevated following LC/HS, and βB prevents this elevation (390 ± 100 pg/mL versus 275 ± 80 pg/mL).
CONCLUSION: βB protection of the BM following shock and injury may be due to reduced HPC mobilization and maintenance of BM cellularity. Following shock, there is an increase in plasma G-CSF and MMP-9, which is abrogated by βB and suggests a possible mechanism how βB decreases HPC mobilization thus preserving BM cellularity. In contrast, βB protection of BM following LC is not mediated by G-CSF. Therefore, the mechanism of progenitor cell mobilization from the BM is dependent on the type of injury. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571320      PMCID: PMC3158299          DOI: 10.1016/j.jss.2011.03.059

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  31 in total

Review 1.  Stem cell mobilization.

Authors:  Michele H Cottler-Fox; Tsvee Lapidot; Isabelle Petit; Orit Kollet; John F DiPersio; Dan Link; Steven Devine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2003

2.  Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.

Authors:  S Shintani; T Murohara; H Ikeda; T Ueno; T Honma; A Katoh; K Sasaki; T Shimada; Y Oike; T Imaizumi
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

3.  Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment.

Authors:  Jean Pierre Lévesque; Jean Hendy; Yasushi Takamatsu; Brenda Williams; Ingrid G Winkler; Paul J Simmons
Journal:  Exp Hematol       Date:  2002-05       Impact factor: 3.084

4.  Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

Authors:  G A McQuibban; G S Butler; J H Gong; L Bendall; C Power; I Clark-Lewis; C M Overall
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

5.  Beta-blockade prevents hematopoietic progenitor cell suppression after hemorrhagic shock.

Authors:  Ihab O Elhassan; Edward J Hannoush; Ziad C Sifri; Eyone Jones; Walter D Alzate; Pranela Rameshwar; David H Livingston; Alicia M Mohr
Journal:  Surg Infect (Larchmt)       Date:  2011-07-26       Impact factor: 2.150

Review 6.  Transfusion practice in the critically ill.

Authors:  Howard L Corwin; Stephen D Surgenor; Andrew Gettinger
Journal:  Crit Care Med       Date:  2003-12       Impact factor: 7.598

7.  Bone marrow failure following severe injury in humans.

Authors:  David H Livingston; Devashish Anjaria; Jonathan Wu; Carl J Hauser; Victor Chang; Edwin A Deitch; Pranela Rameshwar
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

Review 8.  Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.

Authors:  Katsuhiko Suzuki; Shigeyuki Nakaji; Mutsuo Yamada; Manabu Totsuka; Koki Sato; Kazuo Sugawara
Journal:  Exerc Immunol Rev       Date:  2002       Impact factor: 6.308

9.  Beta-blocker use is associated with improved outcomes in adult burn patients.

Authors:  Saman Arbabi; Karla S Ahrns; Wendy L Wahl; Mark R Hemmila; Stewart C Wang; Mary-Margaret Brandt; Paul A Taheri
Journal:  J Trauma       Date:  2004-02

10.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

View more
  18 in total

1.  Does selective beta-1 blockade provide bone marrow protection after trauma/hemorrhagic shock?

Authors:  Latha V Pasupuleti; Kristin M Cook; Ziad C Sifri; Srinath Kotamarti; Gabriel M Calderon; Walter D Alzate; David H Livingston; Alicia M Mohr
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

2.  Clonidine reduces norepinephrine and improves bone marrow function in a rodent model of lung contusion, hemorrhagic shock, and chronic stress.

Authors:  Ines G Alamo; Kolenkode B Kannan; Harry Ramos; Tyler J Loftus; Philip A Efron; Alicia M Mohr
Journal:  Surgery       Date:  2016-10-11       Impact factor: 3.982

Review 3.  Impaired hematopoietic progenitor cells in trauma hemorrhagic shock.

Authors:  Manoj Kumar; Sanjeev Bhoi
Journal:  J Clin Orthop Trauma       Date:  2016-06-22

4.  Role of macrophages in mobilization of hematopoietic progenitor cells from bone marrow after hemorrhagic shock.

Authors:  Meng Xiang; Youzhong Yuan; Liyan Fan; Yuehua Li; Aijun Li; Lianhua Yin; Melanie J Scott; Guozhi Xiao; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  Shock       Date:  2012-05       Impact factor: 3.454

5.  Mesenchymal stem cells reverse bone marrow dysfunction following injury and stress.

Authors:  Amy V Gore; Letitia E Bible; David H Livingston; Alicia M Mohr; Ziad C Sifri
Journal:  J Trauma Acute Care Surg       Date:  2015-10       Impact factor: 3.313

6.  Chronic restraint stress after injury and shock is associated with persistent anemia despite prolonged elevation in erythropoietin levels.

Authors:  Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2015-07       Impact factor: 3.313

7.  Mesenchymal stem cells reverse trauma and hemorrhagic shock-induced bone marrow dysfunction.

Authors:  Amy V Gore; Letitia E Bible; David H Livingston; Alicia M Mohr; Ziad C Sifri
Journal:  J Surg Res       Date:  2015-06-16       Impact factor: 2.192

8.  Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice.

Authors:  John G Noel; Benjamin J Ramser; Jose A Cancelas; Francis X McCormack; Jason C Gardner
Journal:  Exp Hematol       Date:  2017-09-01       Impact factor: 3.084

9.  The Postinjury Inflammatory State and the Bone Marrow Response to Anemia.

Authors:  Tyler J Loftus; Juan C Mira; Elizabeth S Miller; Kolenkode B Kannan; Jessica M Plazas; Daniel Delitto; Julie A Stortz; Jennifer E Hagen; Hari K Parvataneni; Kalia K Sadasivan; Scott C Brakenridge; Frederick A Moore; Lyle L Moldawer; Philip A Efron; Alicia M Mohr
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

10.  Early propranolol administration to severely injured patients can improve bone marrow dysfunction.

Authors:  Letitia E Bible; Latha V Pasupuleti; Walter D Alzate; Amy V Gore; Kim J Song; Ziad C Sifri; David H Livingston; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2014-07       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.